Hexarelin: Theoretical research properties of a synthetic growth hormone-releasing peptide
Hexarelin is a synthetic hexapeptide that emerged from late-20th-century efforts to design growth hormone–releasing peptides (GHRPs).
Hexarelin is a synthetic hexapeptide that emerged from late-20th-century efforts to design growth hormone–releasing peptides (GHRPs).
Within the expanding domain of short-chain bioactive peptides, Decapeptide-12 has emerged as a particularly intriguing molecular construct.
As many as 10 percent of us have had what we think is a near-death experience, which, doing the math, that’s a lot – roughly 36 million in the U.S. alone.
There has been an alarming increase in hospitalizations related to the use of kratom, according to a UVA Health analysis.
The Virginia Tech community is grieving after the loss of a “vibrant” graduate student overnight in Blacksburg.
The Augusta County community raised $80,000 to help support the care, support and research programs of the Alzheimer’s Association.
An Augusta County woman set her sights on a career in research and medicine while she was a patient at UVA Health.
U.S. DOE Secretary Linda McMahon refused to defend her department’s decision to cancel a federal grant program for disabled teens.
Bridgewater College awarded more than $100,000 in funding for students to conduct fulltime research under the mentorship of faculty members.
Millions of Americans deal with balance disorders, and James Madison University researchers will take a look at how it relates to aging.